Dtsch Med Wochenschr 2014; 139(40): 1979-1981
DOI: 10.1055/s-0034-1387217
Angiologie | Commentary
Angiologie
© Georg Thieme Verlag KG Stuttgart · New York

Kathetertherapie der peripheren arteriellen Verschlusskrankheit

Interventional treatment of peripheral artery occlusive disease
A. Schmidt
1   Abteilung für Interventionelle Angiologie des Departments für Innere Medizin, Neurologie, Dermatologie, Universitätsklinikum Leipzig
,
D. Scheinert
1   Abteilung für Interventionelle Angiologie des Departments für Innere Medizin, Neurologie, Dermatologie, Universitätsklinikum Leipzig
› Author Affiliations
Further Information

Publication History

Publication Date:
25 September 2014 (online)

    Permissions and Reprints

Schlüsselwörter

periphere arterielle Verschlusskrankheit - PAVK - Kathetertherapie - Ballonangioplastie - Stentimplantation

Keywords

peripheral artery occlusive disease - PAOD - angioplasty - stent implantation
 

  • Literatur

  • 1 Bonvini RF, Rastan A, Sixt S et al. Angioplasty and provisional stent treatment of common femoral artery lesions. J Vasc Interv Radiol 2013; 24: 175-183
    CrossrefGoogle Scholar
  • 2 Dake MD, Ansel GM, Jaff MR et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions. J Am Coll Cardiol 2013; 61: 2417-2427
    CrossrefGoogle Scholar
  • 3 Fusaro M, Cassese S, Ndrepepa G et al. Drug-eluting stents for revascularization of infrapopliteal arteries. JACC Cardiovasc Interv 2013; 6: 1284-1293
    CrossrefGoogle Scholar
  • 4 Indes JE, Pfaff MJ, Farrokhyar F et al. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease. J Endovasc Ther 2013; 20: 443-455
    CrossrefGoogle Scholar
  • 5 Liistro F, Porto I, Angioli P et al. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK). Circulation 2013; 128: 615-621
    CrossrefGoogle Scholar
  • 6 Pietzsch JB, Geisler BP, Garner AM et al. Economic analysis of endovascular interventions for femoropopliteal arterial diseasey. Catheter Cardiovasc Interv 2014; [Epub ahead of print]
    Google Scholar
  • 7 Rastan A, Krankenberg H, Baumgartner I et al. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery. Circulation 2013; 127: 2535-2541
    CrossrefGoogle Scholar
  • 8 Scheinert D, Duda S, Zeller T et al. The LEVANT I trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv 2014; 7: 10-19
    CrossrefGoogle Scholar
  • 9 Scheinert D, Werner M, Scheinert S et al. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent. JACC Cardiovasc Interv 2013; 6: 65-71
    CrossrefGoogle Scholar
  • 10 Werner M, Micari A, Cioppa A et al. Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery. JACC Cardiovasc Interv 2014; 7: 305-12
    CrossrefGoogle Scholar
  • 11 Werner M, Paetzold A, Banning-Eichenseer U et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention 2014; [Epub ahead of print]
    Google Scholar
  • 12 Zeller T, Baumgartner I, Scheinert D et al. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia. Trials 2014; 15: 63
    CrossrefGoogle Scholar
  • 13 Zeller T, Rastan A, Macharzina R et al. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. J Endovasc Ther 2014; 21: 359-368
    CrossrefGoogle Scholar